192 related articles for article (PubMed ID: 27736024)
1. Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale.
Shu X; Xiong X; Song J; He C; Yi C
Angew Chem Int Ed Engl; 2016 Nov; 55(46):14246-14249. PubMed ID: 27736024
[TBL] [Abstract][Full Text] [Related]
2. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
[TBL] [Abstract][Full Text] [Related]
3. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
4. Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.
Malina J; Kasparkova J; Natile G; Brabec V
Chem Biol; 2002 May; 9(5):629-38. PubMed ID: 12031669
[TBL] [Abstract][Full Text] [Related]
5. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
Wu Y; Bhattacharyya D; King CL; Baskerville-Abraham I; Huh SH; Boysen G; Swenberg JA; Temple B; Campbell SL; Chaney SG
Biochemistry; 2007 Jun; 46(22):6477-87. PubMed ID: 17497831
[TBL] [Abstract][Full Text] [Related]
6. Recognition of cisplatin adducts by cellular proteins.
Kartalou M; Essigmann JM
Mutat Res; 2001 Jul; 478(1-2):1-21. PubMed ID: 11406166
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ
Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180
[TBL] [Abstract][Full Text] [Related]
8. Recognition and repair of DNA-cisplatin adducts.
Woźniak K; Błasiak J
Acta Biochim Pol; 2002; 49(3):583-96. PubMed ID: 12422229
[TBL] [Abstract][Full Text] [Related]
9. Long-term, genome-wide kinetic analysis of the effect of the circadian clock and transcription on the repair of cisplatin-DNA adducts in the mouse liver.
Yang Y; Liu Z; Selby CP; Sancar A
J Biol Chem; 2019 Aug; 294(32):11960-11968. PubMed ID: 31217280
[TBL] [Abstract][Full Text] [Related]
10. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
[TBL] [Abstract][Full Text] [Related]
11. Recognition of platinum-DNA adducts by HMGB1a.
Ramachandran S; Temple B; Alexandrova AN; Chaney SG; Dokholyan NV
Biochemistry; 2012 Sep; 51(38):7608-17. PubMed ID: 22950413
[TBL] [Abstract][Full Text] [Related]
12. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
Lippert B
Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
[TBL] [Abstract][Full Text] [Related]
13. Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis-diamminedichloroplatinum (II) in vivo and in vitro.
Chao CC; Shieh TC; Huang H
FEBS Lett; 1994 Oct; 354(1):103-9. PubMed ID: 7957889
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin.
Trimmer EE; Essigmann JM
Essays Biochem; 1999; 34():191-211. PubMed ID: 10730196
[TBL] [Abstract][Full Text] [Related]
15. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
Zhu G; Myint M; Ang WH; Song L; Lippard SJ
Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
[TBL] [Abstract][Full Text] [Related]
16. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
[TBL] [Abstract][Full Text] [Related]
17. Optimized sample preparation strategy for the analysis of low molecular mass adducts of a fluorescent cisplatin analogue in cancer cell lines by CE-dual-LIF.
Zabel R; Kullmann M; Kalayda GV; Jaehde U; Weber G
Electrophoresis; 2015 Feb; 36(4):509-17. PubMed ID: 25483804
[TBL] [Abstract][Full Text] [Related]
18. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
[TBL] [Abstract][Full Text] [Related]
19. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
Park S; Lippard SJ
Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
[TBL] [Abstract][Full Text] [Related]
20. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
Jung Y; Lippard SJ
Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
